Department of Chemistry, Center of Membrane Sciences, and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506-0055, USA.
J Alzheimers Dis. 2011;25(4):623-33. doi: 10.3233/JAD-2011-110092.
Biliverdin reductase-A (BVR-A) is a pleiotropic enzyme and plays pivotal role in the antioxidant defense against free radicals as well as in cell homeostasis. Together with heme oxygenase, BVR-A forms a powerful system involved in the cell stress response during neurodegenerative disorders including Alzheimer's disease (AD), whereas due to the serine/threonine/tyrosine kinase activity the enzyme regulates glucose metabolism and cell proliferation. In this paper, we report results that demonstrate BVR-A undergoes post-translational oxidative and nitrosative modifications in the hippocampus, but not cerebellum, of subjects with AD and amnestic mild cognitive impairment (MCI). A significant increase of nitrated BVR-A was demonstrated only in AD and MCI hippocampi, whereas no significant modifications were found in cerebellar tissue. In addition, a significant reduction in protein carbonyl-derivatives of BVR-A was found in both AD and MCI hippocampi (15% and 18%, respectively). Biliverdin reductase-bound 4-hydroxynonenals were not modified in hippocampi and cerebella from AD and MCI subjects. These results supported the hypothesis of a prevalence of nitrosative stress-induced modifications on BVR-A structure, and this evidence was confirmed by a significant upregulation of inducible nitric oxide synthase in hippocampal tissue of subjects with AD and MCI that was not present in cerebellum. In conclusion, nitrosative stress-induced modifications on hippocampal BVR-A are an early event in the pathogenesis of AD since they appear also in MCI subjects and could contribute to the antioxidant and metabolic derangement characteristic of these neurodegenerative disorders.
胆红素还原酶-A(BVR-A)是一种多功能酶,在抗氧化防御自由基以及细胞内稳态方面发挥着关键作用。BVR-A 与血红素加氧酶一起形成了一个强大的系统,参与包括阿尔茨海默病(AD)在内的神经退行性疾病中的细胞应激反应,而由于丝氨酸/苏氨酸/酪氨酸激酶活性,该酶调节葡萄糖代谢和细胞增殖。在本文中,我们报告的结果表明,BVR-A 在 AD 和遗忘型轻度认知障碍(MCI)患者的海马体中发生了翻译后氧化和硝化修饰,但在小脑则没有。仅在 AD 和 MCI 的海马体中证明了硝化 BVR-A 的显著增加,而在小脑组织中则没有发现显著的修饰。此外,在 AD 和 MCI 的海马体中均发现 BVR-A 的蛋白羰基衍生物显著减少(分别为 15%和 18%)。BVR-A 结合的 4-羟基壬烯醛在 AD 和 MCI 患者的海马体和小脑组织中均未发生修饰。这些结果支持了硝化应激诱导的 BVR-A 结构修饰普遍存在的假说,并且这一证据得到了诱导型一氧化氮合酶在 AD 和 MCI 患者海马组织中的显著上调的证实,而小脑组织中则没有这种情况。总之,AD 发病机制中的早期事件是海马体 BVR-A 上的硝化应激诱导修饰,因为它们也出现在 MCI 患者中,并且可能导致这些神经退行性疾病的抗氧化和代谢紊乱。